Whitehawk Therapeutics, Inc.
WHWK
$1.57
$0.031.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.32% | 23.04% | 18.85% | -20.14% | -16.93% |
| Total Depreciation and Amortization | 6.82% | 6.82% | 13.95% | 31.58% | -4.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.20% | -9.05% | 11.27% | 94.87% | 43.01% |
| Change in Net Operating Assets | -62.90% | -419.53% | 347.14% | 39.35% | 499.22% |
| Cash from Operations | -56.09% | -31.26% | 45.36% | 7.78% | 14.73% |
| Capital Expenditure | 77.21% | 82.88% | 21.48% | 46.02% | -946.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 198.30% | -61.69% | -105.91% | -36.18% | 105.30% |
| Cash from Investing | 259.91% | -59.86% | -107.06% | -35.36% | 104.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -54.39% | -100.00% | -74.03% | -- | -65.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 102.94% | 100.00% | 85.71% | -- | 92.20% |
| Cash from Financing | -33.75% | 100.00% | -72.20% | -225.00% | 174.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.44% | -1,753.98% | -137.05% | -83.15% | 93.83% |